Sleep disorders in neuromuscular diseases: a narrative review
M Boentert - Clinical and Translational Neuroscience, 2023 - mdpi.com
Neuromuscular disorders (NMDs) encompass a highly diverse group of conditions that affect
the skeletal muscles, peripheral nervous system, or motor endplate. Depending on the …
the skeletal muscles, peripheral nervous system, or motor endplate. Depending on the …
Air pollution and the effectiveness of positive airway pressure therapy in individuals with sleep apnea: a retrospective community-based repeated-measures …
T Kendzerska, M Szyszkowicz, JV Alvarez, R Mallick… - Chest, 2022 - Elsevier
Background Ambient air pollution may affect the severity of untreated OSA, but it is unknown
whether air pollution adversely impacts the effectiveness of positive airway pressure (PAP) …
whether air pollution adversely impacts the effectiveness of positive airway pressure (PAP) …
Pharyngeal inflammation on positron emission tomography/magnetic resonance imaging before and after obstructive sleep apnea treatment
O Cohen, AE Kaufman, H Choi, S Khan… - Annals of the …, 2023 - atsjournals.org
Rationale: There is upper airway inflammation in patients with obstructive sleep apnea
(OSA), which reduces with continuous positive airway pressure (CPAP) therapy. Objectives …
(OSA), which reduces with continuous positive airway pressure (CPAP) therapy. Objectives …
Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea
S Ronnebaum, M Bron, D Patel, D Menno… - Journal of Clinical …, 2021 - jcsm.aasm.org
Study Objectives: Excessive daytime sleepiness associated with obstructive sleep apnea
affects 9%–22% of continuous positive airway pressure–treated patients. An indirect …
affects 9%–22% of continuous positive airway pressure–treated patients. An indirect …
Emerging treatments for insomnia, sleep apnea, and restless leg syndrome among dialysis patients
S Diaz, K Abad, SR Patel, ML Unruh - Seminars in Nephrology, 2021 - Elsevier
Sleep disturbances are highly prevalent in patients with predialysis chronic kidney disease,
end-stage kidney disease, and after a kidney transplant. They contribute to impairment in …
end-stage kidney disease, and after a kidney transplant. They contribute to impairment in …
The OSA patient journey: Pathways for diagnosis and treatment among commercially insured individuals in the United States
EM Wickwire, X Zhang, SH Munson… - Journal of Clinical …, 2024 - jcsm.aasm.org
Study Objectives: The aims of this study were to characterize obstructive sleep apnea (OSA)
care pathways among commercially insured individuals in the United States and to …
care pathways among commercially insured individuals in the United States and to …
Sleep disorders and aging in women
W Akberzie, L Kataria - Clinics in Geriatric Medicine, 2021 - geriatric.theclinics.com
It has been proposed by the US Census Bureau that 20% of the population will be 65 years
old or older by 2030. 1 This is notable because more than half of older patients report …
old or older by 2030. 1 This is notable because more than half of older patients report …
Telehealth technology application in enhancing continuous positive airway pressure adherence in obstructive sleep apnea patients: A review of current evidence
BKS Thong, GXY Loh, JJ Lim, CJL Lee, SN Ting… - Frontiers in …, 2022 - frontiersin.org
Obstructive sleep apnea (OSA) is a common type of sleep-disordered breathing associated
with multiple comorbidities. Continuous positive airway pressure (CPAP) is the first choice …
with multiple comorbidities. Continuous positive airway pressure (CPAP) is the first choice …
2022 Brazilian Thoracic Association recommendations for long-term home oxygen therapy
MVCO Castellano, LFF Pereira, PHR Feitosa… - Jornal Brasileiro de …, 2022 - SciELO Brasil
Some chronic respiratory diseases can cause hypoxemia and, in such cases, long-term
home oxygen therapy (LTOT) is indicated as a treatment option primarily to improve patient …
home oxygen therapy (LTOT) is indicated as a treatment option primarily to improve patient …
Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials
W Meifang, W Ying, C Wen, X Kaizu, S Meiyan… - Heart Failure …, 2024 - Springer
The prevalence of heart failure with preserved ejection fraction (HFpEF) accounts for
approximately 50% of the total heart failure population, and with the aging of the population …
approximately 50% of the total heart failure population, and with the aging of the population …